GlassScriptPhysician profile
Naysi Ojeda
NPI 1851879050
$6,917.90
in general payments reported to CMS, 2019-2025
41 companies · $542 in 2025
The $542 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,801 · 2023: $2,302 · 2024: $1,273 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,827 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,827.32 |
| Education | $289.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $628.19 | 2024-2025 | |
| Janssen Biotech, INC. | $565.43 | 2022-2024 | Tremfya |
| Abbott Laboratories | $534.53 | 2023-2024 | Aveir, Gallant, Jot Dx |
| Amgen INC. | $515.22 | 2022-2025 | Enbrel, Otezla, Evenity |
| Ucb, INC. | $497.95 | 2022-2023 | Cimzia, Nayzilam, Briviact |
| Astrazeneca Pharmaceuticals LP | $476.01 | 2022-2023 | Saphnelo |
| Lilly USA, LLC | $406.87 | 2022-2025 | Taltz, Zepbound, Mounjaro |
| Mallinckrodt Hospital Products INC. | $326.67 | 2022-2023 | Acthar |
| Harmony Biosciences LLC | $322.94 | 2024 | |
| Horizon Therapeutics Plc | $280.27 | 2022 | |
| Abbvie INC. | $256.57 | 2022-2023 | |
| Pfizer INC. | $173.49 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $163.76 | 2022-2025 | |
| Medtronic, INC. | $159.98 | 2023-2024 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Aurinia Pharma U.S., INC. | $150.26 | 2022-2023 | Lupkynis |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naysi Ojeda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.